Max Healthcare Institute Ltd (MAXE.NS) shares jumped 3.1% to ₹1,045.80 in pre-open trade on Tuesday, February 18, 2025, rebounding from recent declines. The surge comes despite the stock's 12.62% drop over the past month, indicating renewed investor confidence. Max Healthcare's strong fundamentals, including a robust PE ratio of 92.42 and a 13.47% return on equity, continue to attract market interest. The company's expansion in the growing healthcare sector and its recent financial performance have contributed to its resilience. With a 52-week high of ₹1,227.95, analysts see potential for further upside as the stock recovers from its recent correction.
Sources: ETMoney, Financial Express, Economic Times